Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer Novel combination therapy will be...
The AI Alliance releases new AI-powered programming language and industrial AI agent framework, adds new Japanese members, and launches AI Alliance Japan
TOKYO, June 26, 2025 /PRNewswire/ -- Today the AI Alliance, a global non-profit consortium dedicated to open-source AI innovation, announced Dana, a new open-source AI-powered programming language, and the OpenDXA agent framework for industrial AI....